Company / Revenue
Oruka Therapeutics, Inc. Revenue History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2023
5-year range
$0 / $0
FY2019-FY2023
Trend
-
vs FY2022
Sector context
#147 of 155
Health Care
What the data says
Remained stable around $0 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 155
▼
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
| FY2015 | $0 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026